Jefferies Maintains Hold on Hims & Hers Health, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Glen Santangelo maintains a Hold rating on Hims & Hers Health (NYSE:HIMS) and raises the price target from $14 to $23.
June 27, 2024 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Glen Santangelo maintains a Hold rating on Hims & Hers Health and raises the price target from $14 to $23.
The raised price target from $14 to $23 by Jefferies indicates a positive outlook on Hims & Hers Health's future performance, which is likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100